evidence: The HHS Secretary declared that circumstances exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic, pursuant to section 564 of the FD&C Act, effective March 27, 2020. The EUA subsequently issued by FDA is listed in the table below this blue box. [...] Revocation notices for COVID-19 drug and biological product EUAs are available at: Emergency Use Authorization--Archived Information. [...] Please see the following pages for EUA templates and additional information about other types of medical device EUAs for COVID-19: